stockrow
Friday 6 November 2026
Export ALPS’s income statement to Excel — free account
Alps Group Inc.
ALPS Healthcare Biotechnology
Alps Group Inc.’s revenue for fiscal 2026 (year ended March 2026) was $4.9 million, up 44.1% from fiscal 2025.
- EPS
- −609.4%
- Free cash flow
- −26.5%
Quarter to September 2025, against a year earlier
0.33
0.02
+6.45%
Follow ALPS
Alert me
| Mar '26 | Sep '25 | Jun '25 | Mar '25 | Older periods | |
|---|---|---|---|---|---|
| — | 25.50% | 19.73% | 14.32% |
+8 more TTM periods Free account |
|
| 0.00% | (17.24%) | (12.10%) | (8.18%) | ||
ROIC |
— | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
— | 31.93% | 25.68% | 19.75% | |
Free Cash Flow per Share |
— | (0.28) | (0.26) | (0.38) | |
Free Cash Flow |
— | (0.96) | (0.91) | (1.31) | |
| Other line items | |||||
Cash ROIC |
— | 8.16% | 7.79% | 12.34% | |
Accounts Payable Turnover |
— | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
— | 0.00 | 0.00 | 0.00 | |
Tax Rate |
— | 0.05 | 0.09 | 0.00 | |
Selling, General and Administrative Expense of Revenue |
— | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
— | (1.13) | (1.51) | (3.26) | |
Operating CF/Net income |
— | 0.35 | 0.45 | 0.98 | |
Revenue per Share |
— | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
— | (0.28) | (0.26) | (0.38) | |
Capex per Share |
— | 0.00 | 0.00 | 0.00 |
Columns are period end dates · fundamentals updated 2 Nov 2026